UK Social Media Regulation Debate Intensifies Campaigners Push for Targeted Under16 Ban Over Blanket Restrictions Stoke Therapeutics STOK Trading at 3009 Key Decision Point 20260520 Ingredion Incorporated INGR Stalls at 10026 Consolidation Phase 20260520 Kalaris Therapeutics KLRS Rallies 436 as Bulls Target 516 20260520 Lexeo Therapeutics LXEO Climbs 1049 Resistance at 520 in Focus 20260520 Megan MGN Declines 659 Amid Market Weakness 20260520 Should You Sell Immix Biopharma IMMX After 248 Drop 20260520